Clinical Trial Update: A Study of Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect of Risk Profile Disclosure on Patient Quality of Life and Fear of Cancer [NA]

View source ↗

Summary

This clinical trial aims to optimize a risk model to predict cancer recurrence in Barrett's esophagus patients and to study the impact of risk-profile disclosur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Esophageal Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Barrett Esophagus, Barrett Esophagus Adenocarcinoma | NA | Status: NOT_YET_RECRUITING